1-3 of 3
Vinay Jain, MBBS, MD, FACP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacokinetic and Pharmacodynamic Analysis of Ocaratuzumab in 50 Patients with Relapsed Follicular Lymphoma and Low-Affinity FcγRIIIa (CD16a) Polymorphisms.

Minna Du, Adrienne O'Reilly, MS, Phuong H Le, MS, Vinay Jain, MBBS, MD, FACP
Journal: Blood
Blood (2012) 120 (21): 2750.
https://doi.org/10.1182/blood.V120.21.2750.2750
Published: 2012
Journal Articles

Anti-Tumor Activity of Low Dose Ocaratuzumab in Previously Treated Follicular Lymphoma Patients with Low-Affinity CD16 Polymorphisms

Phuong H Le, MS, Andres Forero-Torres, MD, Nam H. Dang, MD, PhD, Mitchell R Smith, MD, PhD, Brian K Link, MD, Kristen N. Ganjoo, MD, Kensei Tobinai, MD, PhD, Minna Du, Adrienne O'Reilly, MS, Vinay Jain, MBBS, MD, FACP
Journal: Blood
Blood (2012) 120 (21): 4884.
https://doi.org/10.1182/blood.V120.21.4884.4884
Published: 2012
Journal Articles

Sustained Depletion of B-Cells by a Humanized, Fc-Engineered Anti-CD20 Antibody, AME-133v, in Patients with Relapsed Follicular Lymphoma

Jennifer Wayne, MS, Kristen N. Ganjoo, MD, Andres Forero, MD, Brad Pohlman, MD, Sven de Vos, MD, PhD, Susan P. Carpenter, PhD, James E Wooldridge, MD, Shashidhara Marulappa, DVM, MVSc, MBA, Vinay Jain, MBBS, MD, FACP
Journal: Blood
Blood (2011) 118 (21): 4977.
https://doi.org/10.1182/blood.V118.21.4977.4977
Published: 2011